Frontline Treatment With Chemoimmunotherapy for Limited-Stage Ocular Adnexal MALT Lymphoma With Adverse Factors: A Phase II Study

Oncotarget - United States
doi 10.18632/oncotarget.19788
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Fluorescence in Situhybridization (FISH) Analysis of Primary Ocular Adnexal MALT Lymphoma

BMC Cancer
Cancer ResearchOncologyGenetics
2006English

A Primary Bone Diffuse Large B-Cell Lymphoma With Ocular Adnexal Involvement

Turkish Journal of Haematology
Hematology
2016English

Outcomes for Patients With Mantle Cell Lymphoma Experiencing Frontline Treatment Failure: A Multicenter Retrospective Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Clinical, Histopathological, and Immunogenetic Analysis of Ocular Adnexal Lymphoproliferative Disorders: Characterization of MALT Lymphoma and Reactive Lymphoid Hyperplasia

Modern Pathology
Forensic MedicinePathology
2001English

Ocular Adnexal Lymphoma and Helicobacter Pylori Gastric Infection

American Journal of Hematology
Hematology
2010English

Ocular Adnexal Diffuse Large B-Cell Lymphoma: Local Disease Correlates With Better Outcomes

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2009English

Multigene Methylation Analysis of Ocular Adnexal MALT Lymphoma and Their Relationship toChlamydophila psittaciInfection and Clinical Characteristics in South Korea

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2012English

Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma

British Journal of Haematology
Hematology
2018English

Preliminary Results of a Phase II Study Using Response-Adapted Therapy for Limited-Stage Diffuse Large B-Cell Lymphoma Based on Interim PET/CT

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy